Study of surgery plan for advanced ovarian or peritoneal cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial looks at whether a specific treatment pathway that may include surgery helps people with advanced ovarian (or related) cancer. It mainly involves planning and undergoing a complex pelvic surgery, sometimes after chemotherapy, to improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 70 or older, or age 60+ with major other health problems or limited ability to do daily activities
- You have epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer that is advanced (stage III–IV)
- Your cancer treatment plan includes a surgery meant to remove as much tumor as possible (cytoreductive surgery), as agreed by a team
- Your doctors expect you to live more than 3 months
- You can give informed consent and complete study questionnaires and follow visits reliably
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This trial checks if adjusting the timing of surgery (interval debulking surgery) after chemotherapy can improve outcomes for people with advanced ovarian cancer. It's for those who cannot have surgery right away and will receive chemotherapy first.
This trial tests a personalized (adaptive) chemotherapy plan for people with certain types of ovarian/fallopian tube/peritoneal cancer who already had platinum chemotherapy and a PARP inhibitor. It’s for patients whose cancer came back after (or still responds to) prior platinum treatment and may help delay disease progression.
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
This trial tests giving chemotherapy directly into the abdomen (intraperitoneal) after optimal surgery for advanced ovarian cancer. It aims to see if this approach is safe and effective for women who have already received 3-4 cycles of chemotherapy before surgery.
This trial tests a new combination of two immunotherapy drugs plus standard chemotherapy before surgery for advanced ovarian cancer. The goal is to see if this treatment shrinks the cancer more and makes surgery more effective.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.